Cymabay UK, Ltd
- Company number
- 11238960
- Status
- Dissolved
- Type
- Private Limited Company
- Incorporated
- 7 Mar 2018
- Dissolved
- 14 Jul 2026
- Nature of business
- Research and experimental development on biotechnology
Registered office
Officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| QUINLAN, Paul | Director | 7 Mar 2018 | 29 Feb 2020 |
| OAKWOOD CORPORATE SECRETARY LIMITED | Corporate-Secretary | 7 Mar 2018 | 31 May 2024 |
| SHAH, Sujal | Director | 7 Mar 2018 | 31 May 2024 |
| JORDEN, John Andrew | Director | 31 May 2024 | 27 Nov 2024 |
| MARIN-LAZARO, Juan Peche | Director | 3 Mar 2025 | |
| MCKENZIE, Ian | Secretary | 31 May 2024 | |
| KENNEDY, Thomas Robert | Director | 31 May 2024 |
Control
| Name | Nature of control | Notified | Ceased |
|---|---|---|---|
| Cymabay Therapeutics, Inc. | Ownership Of Shares 75 To 100 Percent Voting Rights 75 To 100 Percent Right To Appoint And Remove Directors |
7 Mar 2018 | 22 Mar 2024 |
| Gilead Sciences, Inc. | Ownership Of Shares 75 To 100 Percent Voting Rights 75 To 100 Percent Right To Appoint And Remove Directors |
22 Mar 2024 |
Connections
Companies at the same address
- Gilead Sciences Europe Ltd (05510315)
- Ouro Medicines Ltd (16049297)